Aerie Pharmaceuticals, Inc. Debt Instrument, Fee Amount
Aerie Pharmaceuticals, Inc. had Debt Instrument, Fee Amount of $6.50 million as of 2019-09-30, per its 10-Q filed 2020-05-07.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentFeeAmount · last filed 2020-05-07
- 2019-09-30: Debt Instrument, Fee Amount $6.50M.
| Period end | Debt Instrument, Fee Amount |
|---|---|
| 2019-09-30 | $6.50M 10-Q · filed 2020-05-07 |